Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

H.S.H. Prince Albert II of Monaco honoured with The Perfect World Foundation Award

The Perfect World Foundation Award is today considered one of the world’s most prestigious awards in the field of conservation and preservation of the natural world.H.S.H. Prince Albert II of Monaco was presented the significant conservation award by The Perfect World Foundation during the organization’s 2022 Arctic Ocean Gala held at the historical Bourse in Gothenburg, Sweden, on the 5[th] of May. His Serene Highness, the ninth recipient of The Perfect World Award, was recognized and honoured for his life-long commitment, dedication, and actions to preserve our oceans. Preceding

#22-160 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Össur hf: Transactions in Relation to Share Buyback Program

Announcement no. 29/2022 9 May 2022 Transactions in relation to share buyback program On 14 February 2022, Össur hf. initiated a share buyback program (“Program”), see Company Announcement no. 05/2022. The purpose of the Program is to reduce the Company’s share capital and adjust the capital structure by distributing capital to shareholders in line with the Company’s Capital Structure and Capital Allocation Policy. The Program will end no later than 23 December 2022, but the Company is entitled to discontinue the Program at any time. The Company may purchase up to 2,000,000

#22-159 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Trading of own shares as part of employee’s savings scheme

SpareBank 1 SR-Bank ASA has on 9 May 2022 purchased 42 200 own shares at an average price of NOK 113,441 Total holdings of own shares after the purchase is 71 040 shares. The shares were acquired as part of SpareBank 1 SR-Bank’s savings scheme for employees. For more information about the saving scheme reference is made to the stock exchange notice dated 20 December 2021, and the stock exchange notice dated 28 April 2022. As part of SpareBank 1 SR-Bank ASA savings scheme the company will acquire additional shares, up to a number of 40 000, within 31 May 2022.

NearForm Makes Strategic Appointments in North America to Bolster Expansion

NearForm has appointed Felicia Schwartz as Head of Delivery for North America and Shaun Anderson as Field CTO.In their new roles, Felicia and Shaun will be focussed on supporting NearForm’s continued US expansion following successful growth investment from Columbia Capital in February 2021.   Felicia and Shaun’s combined years of experience in the world of digital transformation will empower them to lead delivery in the Americas, focussing on helping large enterprises with complex problems,  modernize their legacy systems and build new, agile, customer centric software solutions catered

Marianne K. Knudsen proposed as new Board member of Pagero

Pagero Group AB (publ) today announces that Summa Equity, one of the major shareholders, proposes the election of Marianne K. Knudsen as Board Member in Pagero Group AB during the Annual General Meeting taking place on 12 May. Knudsen has over 20 years of experience delivering business critical and transformational projects in various roles and companies. She is a board member of Vilja Solutions, AquaGreen, and Alexandra Institut. Currently, Knudsen is Co-CEO of ChronosHub ApS, a Danish scale-up company transforming the research publishing process. Prior to joining ChronosHub,

Storebrand ASA: Primary insider transaction

Storebrand ASA EVP Geir Holmgren has today purchased 1,200 shares in Storebrand ASA at NOK 79.10 per share. Geir Holmgren owns 110,038 shares after this transaction. Please see further details about the transactions in the attached form. Lysaker, 9 May 2022 Contact persons: Group Head of Finance & Strategy, Kjetil R. Krøkje: Mobile (+47) 934 12 155 This announcement is subject to information pursuant to the Securities Trading Act § 5-12

Buybacks of series B shares in AB Electrolux during week 18, 2022

During the period May 2 – May 6, 2022 AB Electrolux (LEI code 549300Y3HHZB1ZGFPJ93) has repurchased in total 385,000 own series B shares (ISIN: SE0016589188) as part of the buyback program initiated by the Board of Directors in order to optimize the company’s capital structure.The share buybacks form part of the buyback program of a maximum of 8,000,000 series B shares for a total maximum amount of SEK 1,250 million, which AB Electrolux announced on April 29, 2022. The buyback program, which runs between May 2, 2022 – October 21, 2022, is being carried out in accordance with the Market

Calmark's distributor in India also signs agreements for the Neo products

Calmark Sweden AB announced today that an exclusive distributor agreement has been signed with r2 Diagnostics in India regarding Calmark's test for newborns.As previously announced, Calmark has entered an exclusive distributor agreement with the company r2 Diagnostics regarding marketing and sales of Calmark's COVID19-LDH test in India. This is now being expanded with the Neo products where the first to be launched is Neo-Bilirubin. Every year, about 25 million children are born in India. Of these, it is estimated that about 30% need to take at least one blood sample to ensure bilirubin

Impact evaluation of the fire at Valmet’s Rautpohja factory site in Jyväskylä, Finland, ongoing

Valmet Oyj’s press release May 9, 2022 at 4:45 p.m. EESTThe impact evaluation of a fire that broke out on Saturday May 7 at Valmet’s Rautpohja factory site in Jyväskylä, Finland, is ongoing. The fire, which started at a workshop during a roll test and caused minor injuries to one employee, was fully extinguished over the weekend. The official investigations by the authorities are ongoing at the factory site. The majority of machine workshops at the Rautpohja factory site are unimpacted. Valmet is planning to continue production later this week in these unimpacted machine workshop areas.

Save the date 16 May - Invitation to Munters Investor Relations webinar focused on Data Centers

Welcome to Munters webinar focused on Data Centers, a prioritized growth market for Munters. The webinar will provide an overview of the market as well as Munters strategy and operations. Participants: CEO and President and acting President business area AirTech, Klas Forsström, VP Data Center Technologies, Frank Pellegrino and VP Sales Americas, Data Center Technologies, Keith Dunnavant. The webcast will start on the 16 of May at 13:00 CET (12:00 BST in London, and 07:00 ET in New York) and is estimated to end at 13:45 CET. The event will be webcasted live on Munters Investor

Aptahem enters new consortium financed by the KK Foundation

Aptahem (publ) today announce that the company enters a consortium together with Örebro University, Attgeno AB, BioReperia AB, Buzzard Pharmaceuticals AB, Lipum AB, Thermo Fisher Scientific och Toleranzia AB. The newly established consortium aims to evaluate new treatments to reduce inflammation in cardiovascular diseases and breast cancer.The joint research project, titled Drug discovery targeting inflammation – novel therapeutic aspects on vascular inflammation, thrombosis and breast cancer, has obtained financing from the Swedish KK-foundation and will run over a four-year period with

Buybacks of shares of series B in Trelleborg during week 18, 2022

During the period May 2 to May 6, 2022, Trelleborg AB (LEI code 213800XY16PAWG2PAD14) has repurchased in total 712,827 own shares of series B (ISIN: SE0000114837) as part of the buyback program initiated by the Board of Directors in order adapt the company’s capital structure and thereby contribute to increased shareholder value.   The share buybacks form part of the buyback program of a maximum of 25,272,178 shares of series B for a total maximum amount of SEK 5,000 million, which Trelleborg announced on April 27, 2022. The buyback program, which runs between April 28, 2022, to the

Bioretec Ltd – Managers’ transactions

Bioretec Ltd      Managers’ transactions   9 May 2022 at 16.00 p.m. EESTBioretec Oy - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Sarah van Hellenberg Hubar-Fisher Position: Member of the Board/Deputy member Issuer: Bioretec Oy LEI: 7437008736AG7HY51K13 Notification type: INITIAL NOTIFICATION Reference number: 14589/4/4 ____________________________________________ Transaction date: 2022-05-08 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT

Bioretec Ltd – Managers’ transactions

Bioretec Ltd      Managers’ transactions   9 May 2022 at 16.00 p.m. EESTBioretec Oy - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Päivi Malinen Position: Member of the Board/Deputy member Issuer: Bioretec Oy LEI: 7437008736AG7HY51K13 Notification type: INITIAL NOTIFICATION Reference number: 14583/5/6 ____________________________________________ Transaction date: 2022-05-09 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT

Unique insights into solid-state batteries through new research collaboration

Batteries are essential to achieve a fossil-free and climate-neutral society. Solid-state batteries are considered to be the future within battery technology, although further research is necessary. A new international research project will contribute to the realisation of high-energy density solid-state batteries by studying new battery materials through combined neutron and X-ray imaging.[ANISSA researchers by ODIN control cabin at ESS] Some of the researchers of the ANISSA project by the ODIN instrument's control cabin at ESS in Lund, Sweden. Photo: Julia Öberg/ESS Tomorrow’s

Correction of press release: Missing MAR label in previous press release “RaySearch collaborates with GE Healthcare to improve radiation oncology treatment planning”

RaySearch Laboratories AB (publ) issues a correction of the press release that was sent out at 10:00 May 9, 2022. The correction refers to the fact that the press release lacked the MAR label with reference to the EU Market Abuse Regulation (MAR). The following text should have been included in the press release: This information is information that RaySearch Laboratories AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 10:00 CET on May 9, 2022. The

ASSMANN at the Clerkenwell Design Week in London

Office furniture manufacturer presents furnishing solutions and office furniture for modern working environments at international design festival in LondonAt the Clerkenwell Design Week in London, ASSMANN Office Furniture Ltd. will be presenting its diverse product portfolio for the comprehensive furnishing of innovative working environments and holistic room concepts, inviting visitors to come to its showroom on Turnmill Street from 24 to 26 May 2022. Beautifully designed furniture and inspiring room concepts will be exhibited, as well as ASSMANN 4ROOMS, the service range offering

Appointment of joint corporate brokers

9 May 2022 13:00 BST Appointment of joint corporate brokers AstraZeneca PLC announced that its joint corporate brokers will be Morgan Stanley & Co. International plc and J.P. Morgan Securities plc (which conducts its UK investment banking business as J.P. Morgan Cazenove), effective as of 9 May 2022. AstraZeneca AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal &

Mandatory notification of trade – Shares for employees 2022

Employees in more than 20 countries have been offered the opportunity to buy Orkla shares at a discount, for the amount of NOK 10 000, NOK 15 000 or NOK 30 000 (included the discount). The purchase price will be set at Orkla's closing price on 13 May 2022, minus 15% discount.The offer is valid from 9 – 13 May 2022. This programme was introduced in 1999. Please see the attachment for an overview of the primary insiders who have ordered shares in Orkla on 9 May 2022. The purchase price and the number of shares acquired by the primary insiders, as well as their updated shareholdings,

Corem initiates repurchase of own shares

In accordance with a decision at the Annual General Meeting on 27 April 2022, Corem Property Group AB (publ) will initiate a buyback program of its own shares. Purchase of own shares may take place on one or more occasions during the period until the next Annual General Meeting.At the Annual General Meeting the Board was authorized, until the next Annual General Meeting, to decide on acquiring the company’s own shares. Acquisitions may take place of at most the number of shares so that after each acquisition the group’s total holding of its own shares amounts to at most ten per cent of

Scientific article about the advantageous S2-based protein secretion system ExpreS2 and a moderate-throughput research variant called FAS2FURIOUS

Hørsholm, Denmark, May 9, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that Frontiers in Bioengineering and Biotechnology published an article about the ability of S2 cells to express challenging targets.Excerpts: “…FAS2FURIOUS is comparable in effort to simple E. coli systems and allows users to clone and test up to 46 constructs in just 2 weeks. Given the ability of S2 cells to express challenging targets, including receptor ectodomains, secreted glycoproteins, and viral antigens, FAS2FURIOUS represents an attractive orthogonal

There are no items matching the current filter
There are no more items matching the current filter
Back to top